Tag: helix

BioCardia gets FDA clearance for catheter to guide Helix delivery system

BioCardia has received US Food and Drug Administration (FDA) 510(k) clearance for its Morph DNA deflectable guide catheter, used to guide the Helix biotherapeutic...

Early treatment with Helix system improves ejection fraction and symptoms

The Helix biotherapeutic delivery system (Biocardia), which delivers cell therapy to patients within four weeks of a heart attack, led to improved ejection fraction...

Transendocardial delivery results in greater myocardial stem cell therapy retention

According to a study published in the International Heart Journal, delivery of stem cell therapy to the heart using BioCardia’s Helix transendocardial delivery system...